Argus
•
Jun 17, 2026
CTKB: What does Argus have to say about CTKB?
Summary
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
A: Lowering target price to $165.00
Sep 02, 2026
•
A
BIO: Lowering target price to $400.00
Sep 02, 2026
•
BIO
LFST: What does Argus have to say about LFST?
Sep 02, 2026
•
LFST
Analyst Report: Agilent Technologies, Inc.
Aug 27, 2026
•
A
Analyst Report: Thermo Fisher Scientific Inc.
Aug 26, 2026
•
TMO
